Big stock rally in China bolsters markets across Asia
Chinese stocks surged for a second day on Monday, propelled by a chorus of reassuring comments from leaders and top regulators.
All Posts in "Markets"
AMD earnings: Trade wars could harm assault on Intel
With shares 30% off recent highs, earnings report could help determine if the price is now right
Wages for the 1% just reached their highest level ever
Salaries for the top 1% grew nearly four times the rate of those in the bottom 90% of earners
Saudi Arabia tried to develop a mole inside Twitter: report
The kingdom deployed an army of Twitter trolls to snuff out critics’ voices, the New York Times reported
Investors weigh whether to ditch stocks for bonds as yields finally offer an alternative
Yields still not attractive enough to justify underweighting equities: UBS
Oil sees bounce on Saudi concerns but suffers weekly drop
Oil futures ended higher on Friday, with the global benchmark temporarily pushing back above $80 a barrel on worries about potential U.S.-Saudi tensions, but still saw a weekly decline.
Dollar slides; euro finds footing as EU softens Italy criticism
Investors digest sluggish China GDP and central bank comments
Italy’s stock market ends volatile session flat as budget drama persists
Italy’s FTSE MIB books fourth straight weekly skid
Stock market closes mostly lower as weak data overshadow solid earnings
Friday marks 31st anniversary of the ‘Bloody Monday’ crash
Here’s why investors are anxious about China’s next move
What lesson has China drawn from the devaluation scare in 2015?
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
Denmark’s Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Avantor sells clinical services unit to private equity firm for $650M
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis